COVID-19心血管疾病登记处

为了更好地了解COVID-19大流行, the 美国心脏协会 developed a registry for 医院 and health systems caring for COVID-19 patients.  

作为医生, scientists and researchers worldwide continue to understand the coronavirus (COVID-19) pandemic, the 美国心脏协会's (AHA) COVID-19心血管疾病登记处 serves as an aggregate data source for potential research on the disease, 制定治疗方案, and identification of risk factors tied to adverse cardiovascular outcomes.

”Having sufficient data is the first step to understanding the impact of COVID-19 on cardiovascular health,约翰·华纳说, M.D., FAHA, chair of the quality oversight committee and past volunteer president of the 美国心脏协会 and executive vice president for Health System Affairs at the University of 德州 Southwestern Health System in Dallas, 德州. “As a trusted resource for data and research, with an entry point in more than 2,400 U.S. 医院, the 美国心脏协会 is uniquely positioned to gather data quickly and accurately.”


"Having sufficient data is the first step to understanding the impact of COVID-19 on cardiovascular health"

——约翰·华纳.D., FAHA

The AHA created the COVID-19心血管疾病登记处 to better understand the clinical treatment patterns and variations, 包括生物标记物的收集, and cardiovascular outcomes in hospitalized COVID-19 patients across the nation. The registry focuses on real-time  data from acute care 医院 to better help clinicians and researchers understand and provide feedback to healthcare organizations on how to best treat COVID-19 patients.

The national COVID-19心血管疾病登记处 dataset has been the foundation for numerous publications in peer reviewed journals. These studies have greatly contributed to our collective knowledge on how to best care for patients hospitalized with COVID, 包括有合并症的患者, vulnerable patient populations at greater risk of poor health outcomes, and in-hospital quality of care for patients with COVID.

美国心脏协会的COVID-19心血管疾病登记处由 遵循指南® (GWTG) builds on 20 years of successful hospital quality improvement efforts. The no-cost registry helps inform the larger medical community and the aggregated, deidentified data set is available to researchers through the Association’s Institute for Precision Cardiovascular Medicine.

通过数据抗击COVID-19

在COVID大流行期间, 同事们被放了假, 程序被取消, and many clinicians found themselves more idle and itching to contribute. Tracy Wang, MD, MHS, MS, FAHA shares how these doctors are continuing to impact COVID treatments. 

感谢我们的参与医院!

The 美国心脏协会 recognizes and thanks these 医院 for leading the way toward better health. 

参与医院

美国心脏协会的支持

 
The COVID-19心血管疾病登记处 is supported by the 美国心脏协会 and our Quality and Systems Improvement staff. These experts have been your partners in improving care, understanding the registry elements and are available to answer any questions you may have on how to operationalize the registry at your facility.